North America Continuous Glucose Monitoring Systems (CGMS) Market (2016-2022)

January 2017 | 59 pages | ID: N8A289C3EFFEN
KBV Research

Abstracts

The Continuous Glucose Monitoring Systems (CGMS) devices have witnessed continuous technological evolution CGMS with smartphone connectivity. Wearable CGMS is another promising product with tremendous potential within the wearable healthcare devices. Non-invasive CGMS such as Symphony CGM System, due to its user-friendliness, extensive applications and FDA approvals for the same, have gained prominence over the years. Bionic pancreas is another notable product which is a smart and a complete diabetes management solution which is majorly used for Type I diabetes patients, is another notable breakthrough within the CGMS market.

The component segment of the CGMS market includes transmitters and receivers, sensors and CGMS compatible insulin pumps. Sensors market was the major segment with largest market share in 2015 and is anticipated to register a CAGR of 39% during the forecast period.

The report highlights the adoption of Continuous Glucose Monitoring Systems (CGMS) in North America. Based on the Component, the Global Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are U.S, Canada, Mexico and Rest of North America region.

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Contents

CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 North America Continuous Glucose Monitoring Systems Market, by Component
  1.4.2 North America Continuous Glucose Monitoring Systems Market, by End User
  1.4.3 North America Continuous Glucose Monitoring Systems Market, by Country
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
2.2 Key Influencing Factors
  2.2.1 Drivers
  2.2.2 Restraints
  2.2.3 Opportunities
2.3 North America Continuous Glucose Monitoring Systems Market - By Country

CHAPTER 3. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT

3.1 North America Continuous Glucose Monitoring Systems Sensors Market - By Country
3.2 North America Continuous Glucose Monitoring Transmitters & Receivers Market - By Country
3.3 North America Continuous Glucose Monitoring Systems Integrated Insulin pumps Market - By Country

CHAPTER 4. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER

4.1 North America Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market - By Country
4.2 North America ICUs Continuous Glucose Monitoring Systems Market - By Country
4.3 North America Home Healthcare Continuous Glucose Monitoring Systems Market - By Country

CHAPTER 5. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY

5.1 U.S Continuous Glucose Monitoring Systems Market
  5.1.1 U.S Continuous Glucose Monitoring Systems Market - By Component
  5.1.2 U.S Continuous Glucose Monitoring Systems Market - By End User
5.2 Canada Continuous Glucose Monitoring Systems Market
  5.2.1 Canada Continuous Glucose Monitoring Systems Market - By Component
  5.2.2 Canada Continuous Glucose Monitoring Systems Market - By End User
5.3 Mexico Continuous Glucose Monitoring Systems Market
  5.3.1 Mexico Continuous Glucose Monitoring Systems Market - By Component
  5.3.2 Mexico Continuous Glucose Monitoring Systems Market - By End User
5.4 Rest of North America Continuous Glucose Monitoring Systems Market
  5.4.1 Rest of North America Continuous Glucose Monitoring Systems Market - By Component
  5.4.2 Rest of North America Continuous Glucose Monitoring Systems Market - By End User

CHAPTER 6. COMPANY PROFILE

6.1 Roche Diagnostics.
  6.1.1 Company Overview
  6.1.2 Financial Analysis
  6.1.3 Segmental Analysis
  6.1.4 Research & Development Analysis
6.2 Abbott Laboratories
  6.2.1 Company Overview
  6.2.2 Financial Analysis
  6.2.3 Segmental Analysis
  6.2.4 Research & Development Analysis
6.3 Dexcom, Inc.
  6.3.1 Company Overview
  6.3.2 Financial Analysis
  6.3.3 Research & Development Analysis
6.4 Novo Nordisk.
  6.4.1 Company Overview
  6.4.2 Financial Analysis
  6.4.3 Segmental Analysis
  6.4.4 Research & Development Analysis
6.5 Ypsomed AG
  6.5.1 Company Overview
  6.5.2 Financial Analysis
  6.5.3 Segmental Analysis
6.6 GlySens Incorporated.
  6.6.1 Company Overview
6.7 Medtronic Plc
  6.7.1 Company Overview
  6.7.2 Financial Analysis
  6.7.3 Segmental Analysis
  6.7.4 Research & Development Analysis
6.8 Johnson & Johnson.
  6.8.1 Company Overview
  6.8.2 Financial Analysis
  6.8.3 Research & Development Analysis
  6.8.4 Segmental Analysis

List Of Tables

LIST OF TABLES

TABLE 1 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 2 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 3 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 4 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 5 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 6 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 7 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 8 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 9 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 10 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 11 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 12 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 13 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 14 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 15 NORTH AMERICA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 16 NORTH AMERICA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 17 NORTH AMERICA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 18 NORTH AMERICA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 19 NORTH AMERICA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 20 NORTH AMERICA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 21 U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 22 U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 23 U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 24 U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 25 U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 26 U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 27 CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 28 CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 29 CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 30 CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 31 CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 32 CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 33 MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 34 MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 35 MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 36 MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 37 MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 38 MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 39 REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015
TABLE 40 REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022
TABLE 41 REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2012-2015
TABLE 42 REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY COMPONENT ($MILLION): 2016-2022
TABLE 43 REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2012-2015
TABLE 44 REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY END USER ($MILLION): 2016-2022
TABLE 45 KEY INFORMATION - ROCHE DIAGNOSTICS.
TABLE 46 KEY INFORMATION - ABBOTT LABORATORIES.
TABLE 47 KEY INFORMATION - DEXCOM, INC.
TABLE 48 KEY INFORMATION - NOVO NORDISK.
TABLE 49 KEY INFORMATION - YPSOMED AG.
TABLE 50 KEY INFORMATION - GLYSENS INCORPORATED.
TABLE 51 KEY INFORMATION - MEDTRONIC PLC
TABLE 52 KEY INFORMATION - JOHNSON & JOHNSON.